Literature DB >> 12036891

Multiple PU.1 sites cooperate in the regulation of p40(phox) transcription during granulocytic differentiation of myeloid cells.

Sen-Lin Li1, Anthony J Valente, Mei Qiang, Werner Schlegel, Maria Gamez, Robert A Clark.   

Abstract

The p40(phox) protein, a regulatory component of the phagocyte NADPH oxidase, is preferentially expressed in cells of myeloid lineage. We investigated transcriptional regulation of the p40(phox) gene in HL-60 myeloid cells. Deletion analysis of approximately 6 kb of the 5'-flanking sequence of the gene demonstrated that the proximal 106 base pair of the promoter exhibited maximum reporter activity. This region contains 3 potential binding sites for PU.1, a myeloid-restricted member of the ets family of transcription factors. Mutation or deletion of each PU.1 site decreased promoter activity, and the level of activity mediated by each site correlated with its binding avidity for PU.1, as determined by gel shift competition assays. Mutation of all 3 sites abolished promoter activity in myeloid cells. PU.1-dependent expression was also observed in the Raji B-cell line, whereas the moderate level of promoter reporter activity in the nonmyeloid HeLa cell line was independent of PU.1. Chromatin immunoprecipitation assay demonstrated occupation of the PU.1 sites by PU.1 in vivo in HL-60 cells. Cotransfection of the pGL3-p40-106 reporter construct with a dominant-negative PU.1 mutant dramatically reduced promoter activity, whereas the overexpression of PU.1 increased promoter activity. Promoter activity and transcript levels of p40(phox) increased in HL-60 cells during dimethyl sulfoxide-induced differentiation toward the granulocyte phenotype, and this was associated with increased cellular levels of PU.1 protein. Our findings demonstrate that PU.1 binding at multiple sites is required for p40(phox) gene transcription in myeloid cells and that granulocytic differentiation is associated with the coordinated up-regulation of PU.1 and p40(phox) expression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12036891     DOI: 10.1182/blood.v99.12.4578

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  Anaplasma phagocytophilum modulates gp91phox gene expression through altered interferon regulatory factor 1 and PU.1 levels and binding of CCAAT displacement protein.

Authors:  Venetta Thomas; Swapna Samanta; Caiyun Wu; Nancy Berliner; Erol Fikrig
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

2.  Adipocyte expression of PU.1 transcription factor causes insulin resistance through upregulation of inflammatory cytokine gene expression and ROS production.

Authors:  Ligen Lin; Weijun Pang; Keyun Chen; Fei Wang; Jon Gengler; Yuxiang Sun; Qiang Tong
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-03-27       Impact factor: 4.310

3.  Anaplasma phagocytophilum increases cathepsin L activity, thereby globally influencing neutrophil function.

Authors:  Venetta Thomas; Swapna Samanta; Erol Fikrig
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

4.  HBP1 repression of the p47phox gene: cell cycle regulation via the NADPH oxidase.

Authors:  Stephen P Berasi; Mei Xiu; Amy S Yee; K Eric Paulson
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

5.  Structurally differentiated cis-elements that interact with PU.1 are functionally distinguishable in acute promyelocytic leukemia.

Authors:  Maoxiang Qian; Wen Jin; Xuehua Zhu; Xiaohong Jia; Xianwen Yang; Yanzhi Du; Kankan Wang; Ji Zhang
Journal:  J Hematol Oncol       Date:  2013-04-02       Impact factor: 17.388

6.  Regulation of human formyl peptide receptor 1 synthesis: role of single nucleotide polymorphisms, transcription factors, and inflammatory mediators.

Authors:  Heini M Miettinen
Journal:  PLoS One       Date:  2011-12-09       Impact factor: 3.240

7.  PhyloScan: identification of transcription factor binding sites using cross-species evidence.

Authors:  C Steven Carmack; Lee Ann McCue; Lee A Newberg; Charles E Lawrence
Journal:  Algorithms Mol Biol       Date:  2007-01-23       Impact factor: 1.405

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.